CellSource Co., Ltd. (4880.T)
JPY 844.0
(-1.97%)
JPY 844.0
(-1.97%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 48.88 JPY | -10.38% |
| 2022 | 54.54 JPY | 55.08% |
| 2021 | 35.17 JPY | 131.53% |
| 2020 | 15.19 JPY | 31.52% |
| 2019 | 11.55 JPY | -22.59% |
| 2018 | 14.92 JPY | 131.32% |
| 2017 | 6.45 JPY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 7.88 JPY | 8.39% |
| 2024 Q1 | 7.27 JPY | -43.56% |
| 2024 Q3 | 3.75 JPY | -52.41% |
| 2023 Q3 | 14.03 JPY | 35.16% |
| 2023 FY | - JPY | -10.38% |
| 2023 Q4 | 12.88 JPY | -8.2% |
| 2023 Q2 | 10.38 JPY | -10.21% |
| 2023 Q1 | 11.56 JPY | -49.61% |
| 2022 Q4 | 22.94 JPY | 52.63% |
| 2022 FY | - JPY | 55.08% |
| 2022 Q2 | 8.18 JPY | -2.15% |
| 2022 Q1 | 8.36 JPY | -30.91% |
| 2022 Q3 | 15.03 JPY | 83.74% |
| 2021 Q2 | 8.44 JPY | 37.68% |
| 2021 Q1 | 6.13 JPY | -2.23% |
| 2021 Q3 | 8.64 JPY | 2.37% |
| 2021 Q4 | 12.10 JPY | 40.05% |
| 2021 FY | - JPY | 131.53% |
| 2020 Q4 | 6.27 JPY | 188.94% |
| 2020 Q2 | 2.31 JPY | -47.14% |
| 2020 Q1 | 4.37 JPY | 43.75% |
| 2020 FY | - JPY | 31.52% |
| 2020 Q3 | 2.17 JPY | -6.06% |
| 2019 FY | - JPY | -22.59% |
| 2019 Q4 | 3.04 JPY | 0.0% |
| 2018 FY | - JPY | 131.32% |
| 2017 FY | - JPY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 92.20 JPY | 46.985% |
| PRISM BioLab Co.,LTD | -14.90 JPY | 428.054% |
| GNI Group Ltd. | 169.50 JPY | 71.162% |
| Linical Co., Ltd. | 14.98 JPY | -226.302% |
| Trans Genic Inc. | 0.24 JPY | -20266.667% |
| MEDINET Co., Ltd. | -6.65 JPY | 835.038% |
| Soiken Holdings Inc. | -25.32 JPY | 293.049% |
| Cytori Cell Research Institute, Inc. | 15.47 JPY | -215.966% |
| AnGes, Inc. | -39.29 JPY | 224.408% |
| OncoTherapy Science, Inc. | -6.05 JPY | 907.934% |
| Nxera Pharma Co., Ltd. | -87.17 JPY | 156.074% |
| Immuno-Biological Laboratories Co., Ltd. | 20.05 JPY | -143.791% |
| NanoCarrier Co., Ltd. | -11.10 JPY | 540.36% |
| Carna Biosciences, Inc. | -68.62 JPY | 171.233% |
| CanBas Co., Ltd. | -67.87 JPY | 172.02% |
| D. Western Therapeutics Institute, Inc. | -25.56 JPY | 291.236% |
| RaQualia Pharma Inc. | -14.98 JPY | 426.302% |
| Chiome Bioscience Inc. | -24.62 JPY | 298.538% |
| Kidswell Bio Corporation | -40.23 JPY | 221.501% |
| PeptiDream Inc. | 23.41 JPY | -108.8% |
| Oncolys BioPharma Inc. | -108.92 JPY | 144.877% |
| Ribomic Inc. | -28.70 JPY | 270.314% |
| SanBio Company Limited | -40.48 JPY | 220.751% |
| Healios K.K. | -56.22 JPY | 186.944% |
| BrightPath Biotherapeutics Co., Ltd. | -18.21 JPY | 368.424% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -26.79 JPY | 282.456% |
| Delta-Fly Pharma, Inc. | -198.72 JPY | 124.597% |
| StemRIM | -32.98 JPY | 248.211% |
| FunPep Company Limited | -39.63 JPY | 223.341% |
| Kringle Pharma, Inc. | -158.46 JPY | 130.847% |
| Stella Pharma Corporation | -24.66 JPY | 298.216% |
| TMS Co., Ltd. | -26.02 JPY | 287.855% |
| Noile-Immune Biotech Inc. | -27.25 JPY | 279.376% |
| Cuorips Inc. | -85.87 JPY | 156.923% |
| K Pharma,Inc. | 22.43 JPY | -117.922% |
| Takara Bio Inc. | 12.29 JPY | -297.722% |
| ReproCELL Incorporated | -0.37 JPY | 13310.811% |
| PhoenixBio Co., Ltd. | 6.88 JPY | -610.465% |
| StemCell Institute Inc. | 30.25 JPY | -61.587% |
| Japan Tissue Engineering Co., Ltd. | 3.53 JPY | -1284.703% |
| CellSeed Inc. | -29.43 JPY | 266.089% |